Cholinesterase Inhibitors for Alzheimer's Disease: Multitargeting Strategy Based on Anti-Alzheimer's Drugs Repositioning
出版年份 2019 全文链接
标题
Cholinesterase Inhibitors for Alzheimer's Disease: Multitargeting Strategy Based on Anti-Alzheimer's Drugs Repositioning
作者
关键词
-
出版物
CURRENT PHARMACEUTICAL DESIGN
Volume 25, Issue 33, Pages 3519-3535
出版商
Bentham Science Publishers Ltd.
发表日期
2019-10-09
DOI
10.2174/1381612825666191008103141
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Melatonin in Alzheimer’s Disease: A Latent Endogenous Regulator of Neurogenesis to Mitigate Alzheimer’s Neuropathology
- (2019) Md. Farhad Hossain et al. MOLECULAR NEUROBIOLOGY
- NMDA Receptor Antagonists: Repositioning of Memantine as a Multitargeting Agent for Alzheimer's Therapy
- (2019) Md. Tanvir Kabir et al. CURRENT PHARMACEUTICAL DESIGN
- Emerging signal regulating potential of small molecule biflavonoids to combat neuropathological insults of Alzheimer's disease
- (2019) Md. Sahab Uddin et al. SCIENCE OF THE TOTAL ENVIRONMENT
- Memantine for the Treatment of Dementia: A Review on its Current and Future Applications
- (2018) Jaume Folch et al. JOURNAL OF ALZHEIMERS DISEASE
- APOE and Alzheimer’s Disease: Evidence Mounts that Targeting APOE4 may Combat Alzheimer’s Pathogenesis
- (2018) Md. Sahab Uddin et al. MOLECULAR NEUROBIOLOGY
- Medication compliance in Singaporean patients with Alzheimer’s disease
- (2018) ZK Lum et al. SINGAPORE MEDICAL JOURNAL
- Autophagy and Alzheimer’s Disease: From Molecular Mechanisms to Therapeutic Implications
- (2018) Md. Sahab Uddin et al. Frontiers in Aging Neuroscience
- Reconsideration of Amyloid Hypothesis and Tau Hypothesis in Alzheimer's Disease
- (2018) Fuyuki Kametani et al. Frontiers in Neuroscience
- Analyzing the chance of developing dementia among geriatric people: a cross-sectional pilot study in Bangladesh
- (2018) Md. Sahab Uddin et al. Psychogeriatrics
- Autophagic dysfunction in Alzheimer’s disease: Cellular and molecular mechanistic approaches to halt Alzheimer’s pathogenesis
- (2018) Md. Sahab Uddin et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Nootropic and Anti-Alzheimer’s Actions of Medicinal Plants: Molecular Insight into Therapeutic Potential to Alleviate Alzheimer’s Neuropathology
- (2018) Md. Sahab Uddin et al. MOLECULAR NEUROBIOLOGY
- Discontinuation, Efficacy, and Safety of Cholinesterase Inhibitors for Alzheimer’s Disease: a Meta-Analysis and Meta-Regression of 43 Randomized Clinical Trials Enrolling 16 106 Patients
- (2017) Lídia Blanco-Silvente et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Defining the earliest pathological changes of Alzheimer's disease
- (2016) James C. Vickers et al. Current Alzheimer Research
- Recent progress in repositioning Alzheimer's disease drugs based on a multitarget strategy
- (2016) M Amélia Santos et al. Future Medicinal Chemistry
- Impact of Hypertension on Cognitive Function: A Scientific Statement From the American Heart Association
- (2016) Costantino Iadecola et al. HYPERTENSION
- The comparative efficacy and safety of cholinesterase inhibitors in patients with mild-to-moderate Alzheimer's disease: a Bayesian network meta-analysis
- (2015) Hisanori Kobayashi et al. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY
- Combination Therapy with Cholinesterase Inhibitors and Memantine for Alzheimer’s Disease: A Systematic Review and Meta-Analysis
- (2015) Shinji Matsunaga et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Updating stored memory requires adult hippocampal neurogenesis
- (2015) Irene Suárez-Pereira et al. Scientific Reports
- Galantamine-based Hybrid Molecules with Acetylcholinesterase, Butyrylcholinesterase and γ-Secretase Inhibition Activities
- (2014) L. Vezenkov et al. Current Alzheimer Research
- Design and synthesis of tacrine-phenothiazine hybrids as multitarget drugs for Alzheimer’s disease
- (2014) Ai-ling Hui et al. MEDICINAL CHEMISTRY RESEARCH
- Tacrine-Flurbiprofen Hybrids as Multifunctional Drug Candidates for the Treatment of Alzheimer's Disease
- (2013) Yao Chen et al. ARCHIV DER PHARMAZIE
- Acetylcholinesterase Inhibitors: Pharmacology and Toxicology
- (2013) Mirjana B. Colovic et al. Current Neuropharmacology
- Treatment of Dementia With Lewy Bodies
- (2013) Brendon P. Boot et al. Current Treatment Options in Neurology
- Shifting from the single to the multitarget paradigm in drug discovery
- (2013) José L. Medina-Franco et al. DRUG DISCOVERY TODAY
- A novel series of tacrine–selegiline hybrids with cholinesterase and monoamine oxidase inhibition activities for the treatment of Alzheimer's disease
- (2013) Chuanjun Lu et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Somatic comorbidities and Alzheimer’s disease treatment
- (2013) Alessandra Clodomiro et al. NEUROLOGICAL SCIENCES
- Alzheimer disease in the United States (2010-2050) estimated using the 2010 census
- (2013) L. E. Hebert et al. NEUROLOGY
- Memantine and Cholinesterase Inhibitors: Complementary Mechanisms in the Treatment of Alzheimer’s Disease
- (2013) Chris G. Parsons et al. NEUROTOXICITY RESEARCH
- Neuropathological Alterations in Alzheimer Disease
- (2013) A. Serrano-Pozo et al. Cold Spring Harbor Perspectives in Medicine
- Benefits of combined cholinesterase inhibitor and memantine treatment in moderate–severe Alzheimer's disease
- (2012) Serge Gauthier et al. Alzheimers & Dementia
- Design, synthesis, and evaluation of indanone derivatives as acetylcholinesterase inhibitors and metal-chelating agents
- (2012) Fan-Chao Meng et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Propargylamine-derived multitarget-directed ligands: fighting Alzheimer’s disease with monoamine oxidase inhibitors
- (2012) Irene Bolea et al. JOURNAL OF NEURAL TRANSMISSION
- Cholinergic imbalance in the multiple sclerosis hippocampus
- (2011) Evert-Jan Kooi et al. ACTA NEUROPATHOLOGICA
- Synthesis, Biological Evaluation, and Molecular Modeling of Donepezil andN-[(5-(Benzyloxy)-1-methyl-1H-indol-2-yl)methyl]-N-methylprop-2-yn-1-amine Hybrids as New Multipotent Cholinesterase/Monoamine Oxidase Inhibitors for the Treatment of Alzheimer’s Disease
- (2011) Irene Bolea et al. JOURNAL OF MEDICINAL CHEMISTRY
- The projected effect of risk factor reduction on Alzheimer's disease prevalence
- (2011) Deborah E Barnes et al. LANCET NEUROLOGY
- Tacrine-mefenamic acid hybrids for inhibition of acetylcholinesterase
- (2011) Joshua J. Bornstein et al. MedChemComm
- Interactions of AChE with A? Aggregates in Alzheimer?s Brain: Therapeutic Relevance of IDN 5706
- (2011) Francisco J. Carvajal et al. Frontiers in Molecular Neuroscience
- Dose-dependent CSF acetylcholinesterase inhibition by SDZ ENA 713 in Alzheimer's disease
- (2010) N. R. Cutler et al. ACTA NEUROLOGICA SCANDINAVICA
- Adding Delayed Recall to the Alzheimer Disease Assessment Scale is Useful in Studies of Mild Cognitive Impairment But Not Alzheimer Disease
- (2010) Mary Sano et al. ALZHEIMER DISEASE & ASSOCIATED DISORDERS
- Predictors of adherence among Alzheimer's disease patients receiving oral therapy
- (2010) Bijan Borah et al. CURRENT MEDICAL RESEARCH AND OPINION
- Effects of Cholinesterase Inhibitors on Visual Attention in Drivers With Alzheimer Disease
- (2010) Lori A. Daiello et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Phenothiazine-mediated rescue of cognition in tau transgenic mice requires neuroprotection and reduced soluble tau burden
- (2010) John C O'Leary et al. Molecular Neurodegeneration
- Design, synthesis and biological evaluation of novel dual inhibitors of acetylcholinesterase and β-secretase
- (2009) Yiping Zhu et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Design, synthesis and evaluation of galanthamine derivatives as acetylcholinesterase inhibitors
- (2008) Ping Jia et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started